Teva Pharmaceutical Industries Ltd SEC filings TEVA
Teva Pharmaceutical Industries Ltd has 1,001 filings in SEC EDGAR's recent list, going back to Oct 17, 2017. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 144 | Notice of proposed sale | Nov 5, 2026 | — |
| 144 | Notice of proposed sale | Nov 4, 2026 | — |
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 2, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Oct 29, 2026 | Oct 27, 2026 |
| 3 | Initial insider ownership | Oct 8, 2026 | Sep 29, 2026 |
| 4 | Insider transaction | Sep 22, 2026 | Sep 18, 2026 |
| 4 | Insider transaction | Sep 22, 2026 | Sep 19, 2026 |
| 144 | Notice of proposed sale | Sep 21, 2026 | — |
| 144 | Notice of proposed sale | Sep 18, 2026 | — |
| 8-K |
Current report
Material agreement, New debt
|
Sep 16, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Other events
|
Sep 14, 2026 | Sep 14, 2026 |
| 8-A12B/A | Filing | Sep 14, 2026 | — |
| 25-NSE | Delisting notice | Sep 14, 2026 | — |
| 424B5 | Prospectus supplement | Sep 11, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 11, 2026 | Sep 9, 2026 |
| FWP | Free writing prospectus | Sep 10, 2026 | — |
| FWP | Free writing prospectus | Sep 10, 2026 | — |
| 424B5 | Prospectus supplement | Sep 8, 2026 | — |
| 8-K |
Current report
Other events
|
Sep 3, 2026 | Sep 3, 2026 |
| 8-K |
Current report
Change to shareholder rights
|
Sep 3, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Aug 25, 2026 | Aug 21, 2026 |
| 4 | Insider transaction | Aug 25, 2026 | Aug 21, 2026 |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| 4 | Insider transaction | Aug 10, 2026 | Aug 5, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 3, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 3, 2026 |
| 144 | Notice of proposed sale | Aug 3, 2026 | — |
| 144 | Notice of proposed sale | Aug 3, 2026 | — |
| F-6 POS | Filing | Jul 29, 2026 | — |
| 10-Q | Quarterly report | Jul 29, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 18, 2026 |
| 144 | Notice of proposed sale | Jun 18, 2026 | — |
| 4 | Insider transaction | Jun 16, 2026 | Jun 11, 2026 |
| 144 | Notice of proposed sale | Jun 11, 2026 | — |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 144 | Notice of proposed sale | Jun 5, 2026 | — |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 144 | Notice of proposed sale | Jun 3, 2026 | — |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 28, 2026 | May 28, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 144 | Notice of proposed sale | May 14, 2026 | — |
| 144 | Notice of proposed sale | May 14, 2026 | — |
| 4 | Insider transaction | May 7, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 144 | Notice of proposed sale | May 5, 2026 | — |
| 4 | Insider transaction | May 4, 2026 | May 1, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 144 | Notice of proposed sale | May 4, 2026 | — |
| 144 | Notice of proposed sale | Apr 30, 2026 | — |
| 10-Q | Quarterly report | Apr 29, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 29, 2026 | Apr 29, 2026 |
| DEFA14A | Additional proxy material | Mar 31, 2026 | — |
| ARS | Annual report to shareholders | Mar 31, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Mar 31, 2026 | May 28, 2026 |
| 4 | Insider transaction | Mar 19, 2026 | Mar 17, 2026 |
| 144 | Notice of proposed sale | Mar 17, 2026 | — |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 144 | Notice of proposed sale | Mar 5, 2026 | — |
| 144 | Notice of proposed sale | Mar 5, 2026 | — |
| 144 | Notice of proposed sale | Mar 5, 2026 | — |
| 144 | Notice of proposed sale | Mar 5, 2026 | — |
| 144 | Notice of proposed sale | Mar 5, 2026 | — |
| 144 | Notice of proposed sale | Mar 5, 2026 | — |
| 144 | Notice of proposed sale | Mar 5, 2026 | — |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 144 | Notice of proposed sale | Mar 3, 2026 | — |
| 144 | Notice of proposed sale | Mar 3, 2026 | — |
| 144 | Notice of proposed sale | Mar 3, 2026 | — |
| 144 | Notice of proposed sale | Mar 3, 2026 | — |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 144 | Notice of proposed sale | Feb 26, 2026 | — |
| 3 | Initial insider ownership | Feb 23, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 15, 2026 |
| 144/A | Filing | Feb 18, 2026 | — |
| 144 | Notice of proposed sale | Feb 18, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 9, 2026 | — |
| 10-K | Annual report | Feb 3, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 29, 2026 | Jan 27, 2026 |
| 4 | Insider transaction | Jan 29, 2026 | Jan 27, 2026 |
| 4 | Insider transaction | Jan 29, 2026 | Jan 27, 2026 |
| 4 | Insider transaction | Jan 29, 2026 | Jan 27, 2026 |
| 4 | Insider transaction | Jan 29, 2026 | Jan 27, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 28, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 12, 2026 | Jan 11, 2026 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 144 | Notice of proposed sale | Dec 12, 2025 | — |
| 8-K |
Current report
Material agreement, New debt
|
Dec 11, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 144 | Notice of proposed sale | Dec 9, 2025 | — |
| 144 | Notice of proposed sale | Dec 9, 2025 | — |
| 4 | Insider transaction | Dec 4, 2025 | Dec 2, 2025 |
| 4 | Insider transaction | Dec 1, 2025 | Nov 26, 2025 |
| 144 | Notice of proposed sale | Nov 26, 2025 | — |
| 4 | Insider transaction | Nov 24, 2025 | Nov 20, 2025 |
| 144 | Notice of proposed sale | Nov 20, 2025 | — |
| 4 | Insider transaction | Nov 18, 2025 | Nov 14, 2025 |
| 144 | Notice of proposed sale | Nov 14, 2025 | — |
| 4 | Insider transaction | Nov 10, 2025 | Nov 6, 2025 |
| 4 | Insider transaction | Nov 10, 2025 | Nov 6, 2025 |
| 144/A | Filing | Nov 6, 2025 | — |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2025 | — |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 6, 2025 | — |
| 144 | Notice of proposed sale | Sep 12, 2025 | — |
| 4 | Insider transaction | Sep 9, 2025 | Sep 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2025 | — |
| 4 | Insider transaction | Aug 5, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Aug 5, 2025 | Aug 1, 2025 |
| 144 | Notice of proposed sale | Aug 1, 2025 | — |
| 144 | Notice of proposed sale | Aug 1, 2025 | — |
| 10-Q | Quarterly report | Jul 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2025 | Jul 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 22, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 17, 2025 | — |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 144 | Notice of proposed sale | Jun 12, 2025 | — |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2025 | Jun 5, 2025 |
| 144 | Notice of proposed sale | Jun 3, 2025 | — |
| SD | Specialized disclosure (conflict minerals) | Jun 2, 2025 | — |
| 8-K |
Current report
Material agreement, New debt
|
May 28, 2025 | May 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 22, 2025 | May 20, 2025 |
| 424B5 | Prospectus supplement | May 22, 2025 | — |
| FWP | Free writing prospectus | May 20, 2025 | — |
| 4 | Insider transaction | May 19, 2025 | May 14, 2025 |
| 424B5 | Prospectus supplement | May 19, 2025 | — |
| 4 | Insider transaction | May 12, 2025 | May 8, 2025 |
| 144 | Notice of proposed sale | May 8, 2025 | — |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| UPLOAD | Letter from the SEC | Apr 28, 2025 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TEVA (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Tel Aviv
- SEC filer status
- Large accelerated filer
- SEC CIK
- 818686
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED (until Jan 16, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.